Effects of lithium on inflammation

ACS Chemical Neuroscience

Volumn 5, Issue 6, 2014, Pages 451-458

  Nassar, Ahmad ^a   Azab, Abed N ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cyclooxygenase; cytokines; glia cells; glycogen synthase kinase 3 ; inflammation; lithium; nitric oxide; nuclear factor B; prostaglandins

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GAMMA INTERFERON; GLYCOGEN SYNTHASE KINASE 3BETA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LITHIUM; MEMBRANE PHOSPHOLIPID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLANZAPINE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; AUTACOID; LITHIUM DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; BRAIN CORTEX; CELL GROWTH; CELL PROLIFERATION; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; GLIA CELL; HIPPOCAMPUS; HUMAN; INFLAMMATION; MICROGLIA; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LITHIUM COMPOUNDS;

EID: 84902661980     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn500038f     Document Type: Review

References (143)

1. Narrow, W. E., Rae, D. S., and Robins, L. N. (2002) Revised prevalence estimates of mental disorders in the United States: using clinical significance criterion to reconcile 2 surveys' estimates Arch. Gen. Psychiatry 59, 115-123
2. Cade, J. F. (1949) Lithium salts in the treatment of psychotic excitement Med. J. Aust. 2, 349-352
3. Belmaker, R. H. (2004) Bipolar disorder N. Engl. J. Med. 351, 476-486
4. Gershon, S., Chengappa, K. N., and Malhi, G. S. (2009) Lithium specificity in bipolar illness: a classic agent for the classic disorder Bipolar Disord. 11, 34-44
5. Baldessarini, R. J. and Tondo, L. (2009) Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants Pharmacopsychiatry 42, 72-75
6. Berridge, M. J. and Irvine, R. F. (1989) Inositol phosphates and cell signaling Nature 341, 197-204
7. Klein, P. S. and Melton, D. A. (1996) A molecular mechanism for the effect of lithium on development Proc. Natl. Acad. Sci. U.S.A. 93, 8455-8459
8. Stambolic, V., Ruel, L., and Woodgett, J. R. (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells Curr. Biol. 6, 1664-1668
9. Goldstein, B. I., Kemp, D. E., Soczynska, J. K., and McIntyre, R. S. (2009) Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature J. Clin. Psychiatry. 70, 1078-1090
10. Maes, M. (2010) Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 664-675
11. Munkholm, K., Braüner, J. V., Kessing, L. V., and Vinberg, M. (2013) Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis J. Psychiatr. Res. 47, 1119-1133
12. Modabbernia, A., Taslimi, S., Brietzke, E., and Ashrafi, M. (2013) Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies Biol. Psychiatry 74, 15-25
13. Rao, J. S., Harry, G. J., Rapoport, S. I., and Kim, H. W. (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients Mol. Psychiatry 15, 384-392
14. Kim, H. W., Rapoport, S. I., and Rao, J. S. (2011) Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients Mol. Psychiatry 16, 419-428
15. Söderlund, J., Olsson, S. K., Samuelsson, M., Walther-Jallow, L., Johansson, C., Erhardt, S., Landén, M., and Engberg, G. (2011) Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder J. Psychiatry Neurosci. 36, 114-118
16. Murphy, D. L., Goodwin, F. K., and Bunney, W. E., Jr. (1971) Leukocytosis during lithium treatment Am. J. Psychiatry 127, 1559-1561
17. Rothstein, G., Clarkson, D. R., Larsen, W., Grosser, B. I., and Athens, J. W. (1978) Effect of lithium on neutrophil mass and production N. Engl. J. Med. 298, 178-180
18. Lyman, G. H., Williams, C. C., and Preston, D. (1980) The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy N. Engl. J. Med. 302, 257-260
19. Kramlinger, K. G. and Post, R. M. (1990) Addition of lithium carbonate to carbamazepine: hematological and thyroid effects Am. J. Psychiatry 147, 615-620
20. Murphy, D. L., Donnelly, C., and Moskowitz, J. (1973) Inhibition by lithium of prostaglandin E1 and norepinephrine effects on cyclic adenosine monophosphate production in human platelets Clin. Pharmacol. Ther. 14, 810-814
21. Karmazyn, M., Manku, M. S., and Horrobin, D. F. (1978) Changes of vascular reactivity induced by low vasopressin concentrations: interactions with cortisol and lithium and possible involvement of prostaglandins Endocrinology 102, 1230-1236
22. Goetzl, E. J., An, S., and Smith, W. L. (1995) Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases FASEB. J. 9, 1051-1058
23. Smith, W. L., Garavito, R. M., and De Witt, D. L. (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 J. Biol. Chem. 271, 33157-33160
24. Rao, J. S., Lee, H. J., Rapoport, S. I., and Bazinet, R. P. (2008) Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol. Psychiatry 13, 585-596
25. Chang, M. C., Grange, E., Rabin, O., Bell, J. M., Allen, D. D., and Rapoport, S. I. (1996) Lithium decreases turnover of arachidonate in several brain phospholipids Neurosci. Lett. 220, 171-174
26. Chang, M. C. and Jones, C. R. (1998) Chronic lithium treatment decreases brain phospholipase A2 activity Neurochem. Res. 23, 887-892
27. Bosetti, F., Rintala, J., Seemann, R., Rosenberger, T. A., Contreras, M. A., Rapoport, S. I., and Chang, M. C. (2002) Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain Mol. Psychiatry 7, 845-850
28. Basselin, M., Kim, H. W., Chen, M., Ma, K., Rapoport, S. I., Murphy, R. C., and Farias, S. E. (2010) Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation J. Lipid. Res. 51, 1049-1056
29. Ziboh, V. A., Miller, C. C., and Cho, Y. (2000) Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites Am. J. Clin. Nutr. 71, 361S-366S
30. Hong, S., Gronert, K., Devchand, P. R., Moussignac, R. L., and Serhan, C. N. (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation J. Biol. Chem. 278, 14677-14687
31. González-Périz, A., Planagumà, A., Gronert, K., Miquel, R., López-Parra, M., Titos, E., Horrillo, R., Ferré, N., Deulofeu, R., Arroyo, V., Rodés, J., and Clària, J. (2006) Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA FASEB. J. 20, 2537-2539
32. Weylandt, K. H., Krause, L. F., Gomolka, B., Chiu, C. Y., Bilal, S., Nadolny, A., Waechter, S. F., Fischer, A., Rothe, M., and Kang, J. X. (2011) Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α Carcinogenesis 32, 897-903
33. Chiu, C. Y., Gomolka, B., Dierkes, C., Huang, N. R., Schroeder, M., Purschke, M., Manstein, D., Dangi, B., and Weylandt, K. H. (2012) Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis Inflammation Res. 61, 967-976
34. Nahman, S., Belmaker, R. H., and Azab, A. N. (2012) Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells Innate Immun. 18, 447-458
35. Wang, H. M., Zhang, T., Li, Q., Huang, J. K., Chen, R. F., and Sun, X. J. (2013) Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes Neurochem. Int. 63, 345-353
36. Chang, M. C., Contreras, M. A., Rosenberger, T. A., Rintala, J. J., Bell, J. M., and Rapoport, S. I. (2001) Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers J. Neurochem. 77, 796-803
37. Bazinet, R. P., Rao, J. S., Chang, L., Rapoport, S. I., and Lee, H. J. (2006) Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder Biol. Psychiatry 59, 401-407
38. Lee, H. J., Ertley, R. N., Rapoport, S. I., Bazinet, R. P., and Rao, J. S. (2008) Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex Neurochem. Res. 33, 861-866
39. Cheon, Y., Park, J. Y., Modi, H. R., Kim, H. W., Lee, H. J., Chang, L., Rao, J. S., and Rapoport, S. I. (2011) Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E2 concentration in rat brain J. Neurochem. 119, 364-376
40. Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein.-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., Möller, H. J., Arolt, V., and Riedel, M. (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Mol. Psychiatry. 11, 680-684
41. Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta-Soares, G. B., Frey, B. N., Bowden, C. L., and Soares, J. C. (2008) Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study Hum. Psychopharmacol. 23, 87-94
42. Voutsinos-Porche, B., Koning, E., Kaplan, H., Ferrandon, A., Guenounou, M., Nehlig, A., and Motte, J. (2004) Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy Neurobiol. Dis. 17, 385-402
43. Yuskaitis, C. J. and Jope, R. S. (2009) Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity Cell. Signalling 21, 264-273
44. Knowles, R. G. and Moncada, S. (1994) Nitric oxide synthases in mammals Biochem. J. 298, 249-258
45. Merrill, J. E., Murphy, S. P., Mitrovic, B., Mackenzie-Graham, A., Dopp, J. C., Ding, M., Griscavage, J., Ignarro, L. J., and Lowenstein, C. J. (1997) Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes J. Neurosci. Res. 48, 372-384
46. Moncada, S. and Bolanos, J. P. (2006) Nitric oxide, cell bioenergetics and neurodegeneration J. Neurochem. 97, 1676-1689
47. Bagetta, G., Massoud, R., Rodinò, P., Federici, G., and Nisticò, G. (1993) Systemic administration of lithium chloride and tacrine increases nitric oxide synthase activity in the hippocampus of rats Eur. J. Pharmacol. 237, 61-64
48. Harvey, B. H., Carstens, M. E., and Taljaard, J. J. (1994) Evidence that lithium induces a glutamatergic: nitric oxide-mediated response in rat brain Neurochem. Res. 19, 469-474
49. Anai, H., Ueta, Y., Serino, R., Nomura, M., Nakashima, Y., and Yamashita, H. (2001) Activation of hypothalamic neuronal nitric oxide synthase in lithium-induced diabetes insipidus rats Psychoneuroendocrinology 26, 109-120
50. Du, Q., Park, K. S., Guo, Z., He, P., Nagashima, M., Shao, L., Sahai, R., Geller, D. A., and Hussain, S. P. (2006) Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling Cancer Res. 66, 7024-7031
51. Bandino, A., Compagnone, A., Bravoco, V., Cravanzola, C., Lomartire, A., Rossetto, C., Novo, E., Cannito, S., Valfré di Bonzo, L., Zamara, E., Autelli, R., Parola, M., and Colombatto, S. (2008) Beta-catenin triggers nuclear factor kappaB-dependent up-regulation of hepatocyte inducible nitric oxide synthase Int. J. Biochem. Cell Biol. 40, 1861-1871
52. Ghasemi, M. and Dehpour, A. R. (2011) The NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithium Trends Pharmacol. Sci. 32, 420-434
53. Talab, S. S., Elmi, A., Emami, H., Nezami, B. G., Assa, S., Ghasemi, M., Tavangar, S. M., and Dehpour, A. R. (2012) Protective effects of acute lithium preconditioning against renal ischemia/reperfusion injury in rat: role of nitric oxide and cyclooxygenase systems Eur. J. Pharmacol. 681, 94-99
54. Schwabe, R. F. and Brenner, D. A. (2002) Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes Am. J. Physiol.: Gastrointest. Liver Physiol. 283, G204-211
55. Wegener, G., Bandpey, Z., Heiberg, I. L., Volke, V., Trabace, L., Rosenberg, R., and Harvey, B. H. (2004) Combined chronic treatment with citalopram and lithium does not modify the regional neurochemistry of nitric oxide in rat brain J. Physiol. Pharmacol. 55, 575-586
56. Maruta, S., Suzuki, E., Yokoyama, M., Sato, T., Inada, K., Watanabe, S., and Miyaoka, H. (2005) Effects of intraperitoneally injected lithium, imipramine and diazepam on nitrate levels in rat amygdala Psychiatry Clin. Neurosci. 59, 358-361
57. Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., and Kanba, S. (2007) Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide Exp. Neurol. 206, 33-42
58. Bhalla, P., Singla, N., and Dhawan, D. K. (2010) Potential of lithium to reduce aluminium-induced cytotoxic effects in rat brain Biometals 23, 197-206
59. Koriyama, Y., Nakayama, Y., Matsugo, S., Sugitani, K., Ogai, K., Takadera, T., and Kato, S. (2013) Anti-inflammatory effects of lipoic acid through inhibition of GSK-3β in lipopolysaccharide-induced BV-2 microglial cells Neurosci. Res. 77, 87-96
60. Shintani, F., Kanba, S., Nakaki, T., Nakamura, R., Sato, K., Yagi, G., Richelson, E., Kato, R., and Asai, M. (1994) Inhibition by lithium of cyclic GMP formation without inhibition of nitric oxide generation in the mouse neuroblastoma cell (N1E-115) Neuropsychopharmacology 11, 119-124
61. Suzuki, E., Nakaki, T., Shintani, F., Kanba, S., and Miyaoka, H. (2002) Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain Neurosci. Lett. 333, 217-219
62. Luna-Medina, R., Cortes-Canteli, M., Alonso, M., Santos, A., Martínez, A., and Perez-Castillo, A. (2005) Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation J. Biol. Chem. 280, 21453-21462
63. Kleinerman, E. S., Knowles, R. D., Blick, M. B., and Zwelling, L. A. (1989) Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin J. Leukocyte Biol. 46, 484-492
64. Merendino, R. A., Mancuso, G., Tomasello, F., Gazzara, D., Cusumano, V., Chillemi, S., Spadaro, P., and Mesiti, M. (1994) Effects of lithium carbonate on cytokine production in patients affected by breast cancer J. Biol. Regul. Homeostatic Agents 8, 88-91
65. Victoratos, P., Yiangou, M., Avramidis, N., and Hadjipetrou, L. (1997) Regulation of cytokine gene expression by adjuvants in vivo Clin. Exp. Immunol. 109, 569-578
66. Maes, M., Song, C., Lin, A. H., Pioli, R., Kenis, G., Kubera, M., and Bosmans, E. (1999) In vitro immunoregulatory effects of lithium in healthy volunteers Psychopharmacology (Berlin, Ger.). 143, 401-407
67. Ballanger, F., Tenaud, I., Volteau, C., Khammari, A., and Dréno, B. (2008) Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis Arch. Dermatol. Res. 300, 215-223
68. Guloksuz, S., Cetin, E. A., Cetin, T., Deniz, G., Oral, E. T., and Nutt, D. J. (2010) Cytokine levels in euthymic bipolar patients J. Affective Disord. 126, 458-462
69. Liu, K. J., Lee, Y. L., Yang, Y. Y., Shih, N. Y., Ho, C. C., Wu, Y. C., Huang, T. S., Huang, M. C., Liu, H. C., Shen, W. W., and Leu, S. J. (2011) Modulation of the development of human monocyte-derived dendritic cells by lithium chloride J. Cell. Physiol. 226, 424-433
70. Matsebatlela, T., Gallicchio, V., and Becker, R. (2012) Lithium modulates cancer cell growth, apoptosis, gene expression and cytokine production in HL-60 promyelocytic leukaemia cells and their drug-resistant sub-clones Biol. Trace Elem. Res. 149, 323-330
71. Hull, M., Lee, E., Lee, T., Anand, N., LaLone, V., and Parameswaran, N. (2014) Lithium chloride induces TNFα in mouse macrophages via MEK-ERK-dependent pathway J. Cell. Biochem. 115, 71-80
72. Arena, A., Capozza, A. B., Orlando, M. E., Currò, F., Losi, E., Chillemi, S., Mesiti, M., and Merendino, R. A. (1997) In vitro effects of lithium chloride on TNF alpha and IL-6 production by monocytes from breast cancer patients J. Chemother. 9, 219-226
73. Martin, M., Rehani, K., Jope, R. S., and Michalek, S. M. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3 Nat. Immunol. 6, 777-784
74. Zhang, P., Katz, J., and Michalek, S. M. (2009) Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice Mol. Immunol. 46, 677-687
75. Wang, Y., Huang, W. C., Wang, C. Y., Tsai, C. C., Chen, C. L., Chang, Y. T., Kai, J. I., and Lin, C. F. (2009) Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis Br. J. Pharmacol. 157, 1004-1013
76. Daneshmand, A., Rahimian, R., Mohammadi, H., Ejtemaee-Mehr, S., Tavangar, S. M., Babaei Kelishomi, R., and Dehpour, A. R. (2009) Protective effects of lithium on acetic acid-induced colitis in rats Dig. Dis. Sci. 54, 1901-1907
77. Park, H. J., Kim, H. J., Bae, G. S., Seo, S. W., Kim, D. Y., Jung, W. S., Kim, M. S., Song, M. Y., Kim, E. K., Kwon, K. B., Hwang, S. Y., Song, H. J., Park, C. S., Park, R. K., Chong, M. S., and Park, S. J. (2009) Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells Hear. Res. 257, 53-62
78. Tan, W. F., Cao, X. Z., Wang, J. K., Lv, H. W., Wu, B. Y., and Ma, H. (2010) Protective effects of lithium treatment for spatial memory deficits induced by tau hyperphosphorylation in splenectomized rats Clin. Exp. Pharmacol. Physiol. 37, 1010-1015
79. Al-Azemi, M., Omu, F. E., Kehinde, E. O., Anim, J. T., Oriowo, M. A., and Omu, A. E. (2010) Lithium protects against toxic effects of cadmium in the rat testes J. Assisted Reprod. Genet. 27, 469-476
80. Coant, N., Simon-Rudler, M., Gustot, T., Fasseu, M., Gandoura, S., Ragot, K., Abdel-Razek, W., Thabut, D., Lettéron, P., Ogier-Denis, E., Ouziel, R., Devière, J., Lizard, G., Tellier, Z., Lebrec, D., and Moreau, R. (2011) Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis J. Hepatol. 55, 784-793
81. Daneshmand, A., Mohammadi, H., Rahimian, R., Habibollahi, P., Fakhfouri, G., Talab, S. S., Mehr, S. E., and Dehpour, A. R. (2011) Chronic lithium administration ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels J. Gastroenterol. Hepatol. 26, 1174-1181
82. Tay, T. F., Maheran, M., Too, S. L., Hasidah, M. S., Ismail, G., and Embi, N. (2012) Glycogen synthase kinase-3β inhibition improved survivability of mice infected with Burkholderia pseudomallei Trop. Biomed. 29, 551-567
83. Green, H. F. and Nolan, Y. M. (2012) GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia Neurochem. Int. 61, 666-671
84. Albayrak, A., Halici, Z., Polat, B., Karakus, E., Cadirci, E., Bayir, Y., Kunak, S., Karcioglu, S. S., Yigit, S., Unal, D., and Atamanalp, S. S. (2013) Protective effects of lithium: a new look at an old drug with potential antioxidative and anti-inflammatory effects in an animal model of sepsis Int. Immunopharmacol. 16, 35-40
85. Chen, K., Wu, Y., Zhu, M., Deng, Q., Nie, X., Li, M., Wu, M., and Huang, X. (2013) Lithium chloride promotes host resistance against Pseudomonas aeruginosa keratitis Mol. Vision 19, 1502-1514
86. Agrawal, S., Gollapudi, S., Gupta, S., and Agrawal, A. (2013) Dendritic cells from the elderly display an intrinsic defect in the production of IL-10 in response to lithium chloride Exp. Gerontol. 48, 1285-1292
87. Kwon, Y. J., Yoon, C. H., Lee, S. W., Park, Y. B., Lee, S. K., and Park, M. C. (2013) Inhibition of glycogen synthase kinase-3β suppresses inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes and collagen-induced arthritis Joint Bone Spine 10.1016/j.jbspin.2013.09.006
88. Kang, K., Kim, Y. J., Kim, Y. H., Roh, J. N., Nam, J. M., Kim, P. Y., Ryu, W. S., Lee, S. H., and Yoon, B. W. (2012) Lithium pretreatment reduces brain injury after intracerebral hemorrhage in rats Neurol. Res. 34, 447-454
89. Himmerich, H., Bartsch, S., Hamer, H., Mergl, R., Schönherr, J., Petersein, C., Munzer, A., Kirkby, K. C., Bauer, K., and Sack, U. (2013) Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro J. Psychiatr. Res. 47, 1751-1759
90. Kucharz, E. J., Sierakowski, S., Staite, N. D., and Goodwin, J. S. (1988) Mechanism of lithium-induced augmentation of T-cell proliferation Int. J. Immunopharmacol. 10, 253-259
91. Zhu, Z. F., Wang, Q. G., Han, B. J., and William, C. P. (2010) Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice Brain Res. Bull. 83, 272-277
92. Li, H., Li, Q., Du, X., Sun, Y., Wang, X., Kroemer, G., Blomgren, K., and Zhu, C. (2011) Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells J. Cereb. Blood Flow Metab. 31, 2106-2115
93. Zhao, L., Wang, F., Gui, B., Hua, F., and Qian, Y. (2011) Prophylactic lithium alleviates postoperative cognition impairment by phosphorylating hippocampal glycogen synthase kinase-3β (Ser9) in aged rats Exp. Gerontol. 46, 1031-1036
94. Knijff, E. M., Breunis, M. N., Kupka, R. W., de Wit, H. J., Ruwhof, C., Akkerhuis, G. W., Nolen, W. A., and Drexhage, H. A. (2007) An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment Bipolar Disord. 9, 743-753
95. Kishter, S., Hoffman, F. A., and Pizzo, P. A. (1985) Production of and response to interleukin-2 by cultured T cells: effects of lithium chloride and other putative modulators J. Biol. Response Modif. 4, 185-194
96. Sztein, M. B., Simon, G. L., Parenti, D. M., Scheib, R., Goldstein, A. L., Goodman, R., DiGioia, R., Paxton, H., Skotnicki, A. B., and Schulof, R. S. (1987) In vitro effects of thymosin and lithium on lymphoproliferative responses of normal donors and HIV seropositive male homosexuals with AIDS-related complex Clin. Immunol. Immunopathol. 44, 51-62
97. Wilson, R., Fraser, W. D., McKillop, J. H., Smith, J., O'Reilly, D. S., and Thomson, J. A. (1989) The "in vitro" effects of lithium on the immune system Autoimmunity 4, 109-114
98. Beyaert, R., Schulze-Osthoff, K., Van Roy, F., and Fiers, W. (1991) Lithium chloride potentiates tumor necrosis factor-induced and interleukin 1-induced cytokine and cytokine receptor expression Cytokine 3, 284-291
99. Wu, Y. Y. and Yang, X. H. (1991) Enhancement of interleukin 2 production in human and Gibbon T cells after in vitro treatment with lithium Proc. Soc. Exp. Biol. Med. 198, 620-624
100. Kucharz, E. J., Sierakowski, S. J., and Goodwin, J. S. (1993) Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus Immunopharmacol. Immunotoxicol. 15, 515-523
101. Rapaport, M. H., Guylai, L., and Whybrow, P. (1999) Immune parameters in rapid cycling bipolar patients before and after lithium treatment J. Psychiatr. Res. 33, 335-340
102. Ohteki, T., Parsons, M., Zakarian, A., Jones, R. G., Nguyen, L. T., Woodgett, J. R., and Ohashi, P. S. (2000) Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3 J. Exp. Med. 192, 99-104
103. Szuster-Ciesielska, A., Tustanowska-Stachura, A., Słotwiń ska, M., Marmurowska-Michałowska, H., and Kandefer-Szerszeń, M. (2003) In vitro immunoregulatory effects of antidepressants in healthy volunteers Pol. J. Pharmacol. 55, 353-362
104. Rapaport, M. H. and Manji, H. K. (2001) The effects of lithium on ex vivo cytokine production Biol. Psychiatry 50, 217-224
105. Boufidou, F., Nikolaou, C., Alevizos, B., Liappas, I. A., and Christodoulou, G. N. (2004) Cytokine production in bipolar affective disorder patients under lithium treatment J. Affective Disord. 82, 309-313
106. De Sarno, P., Axtell, R. C., Raman, C., Roth, K. A., Alessi, D. R., and Jope, R. S. (2008) Lithium prevents and ameliorates experimental autoimmune encephalomyelitis J. Immunol. 181, 338-345
107. Natsume, H., Tokuda, H., Adachi, S., Matsushima-Nishiwaki, R., Kato, K., Minamitani, C., Otsuka, T., and Kozawa, O. (2011) Wnt3a regulates tumor necrosis factor-α-stimulated interleukin-6 release in osteoblasts Mol. Cell. Endocrinol. 331, 66-72
108. Beurel, E. and Jope, R. S. (2009) Glycogen synthase kinase-3 promotes the synergistic action of interferon-gamma on lipopolysaccharide-induced IL-6 production in RAW264.7 cells Cell. Signalling 21, 978-985
109. Beurel, E. and Jope, R. S. (2009) Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain J. Neuroinflammation 10.1186/1742-2094-6-9
110. McGrath, H. E., Wade, P. M., Kister, V. K., and Quesenberry, P. J. (1992) Lithium stimulation of HPP-CFC and stromal growth factor production in murine Dexter culture J. Cell. Physiol. 151, 276-286
111. Vandevoorde, V., Haegeman, G., and Fiers, W. (1992) TNF-mediated IL6 gene expression and cytotoxicity are co-inducible in TNF-resistant L929 cells FEBS Lett. 302, 235-238
112. Vines, A., Cahoon, S., Goldberg, I., Saxena, U., and Pillarisetti, S. (2006) Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expression J. Biol. Chem. 281, 16985-16990
113. Baban, B., Liu, J. Y., and Mozaffari, M. S. (2013) Pressure overload regulates expression of cytokines, γH2AX, and growth arrest- and DNA-damage inducible protein 153 via glycogen synthase kinase-3β in ischemic-reperfused hearts Hypertension 61, 95-104
114. Sharma, S. D. (1982-1983) Lithium modulates mitogen induced natural killer activity and interferon production Immunopharmacology 4, 303-313
115. Rowse, A. L., Naves, R., Cashman, K. S., McGuire, D. J., Mbana, T., Raman, C., and De Sarno, P. (2012) Lithium controls central nervous system autoimmunity through modulation of IFN-γ signaling PLoS One 7 (12) e52658
116. Wang, L., Zhang, L., Zhao, X., Zhang, M., Zhao, W., and Gao, C. (2013) Lithium attenuates IFN-β production and antiviral response via inhibition of TANK-binding kinase 1 kinase activity J. Immunol. 191, 4392-8398
117. Aschner, M. (1998) Immune and inflammatory responses in the CNS: modulation by astrocytes Toxicol. Lett. 102-103, 283-287
118. Allen, N. J. and Barres, B. A. (2009) Neuroscience: Glia-more than just brain glue Nature 457, 675-677
119. Kreutzberg, G. W. (1996) Microglia: a sensor for pathological events in the CNS Trends Neurosci. 19, 312-318
120. Shemi, D., Azab, A. N., and Kaplanski, J. (2001) Time-dependent effect of LPS on PGE2 and TNF-α production by rat glial brain culture: influence of COX and cytokine inhibitors J. Endotoxin Res. 6, 377-381
121. Rajkowska, G., Halaris, A., and Selemon, L. D. (2001) Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder Biol. Psychiatry 49, 741-752
122. Rajkowska, G. (2002) Cell pathology in bipolar disorder Bipolar Disord. 4, 105-116
123. Watkins, C. C., Sawa, A., and Pomper, M. G. (2014) Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application Transl. Psychiatry 4, e350
124. Cotter, D., Mackay, D., Landau, S., Kerwin, R., and Everall, I. (2001) Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder Arch. Gen. Psychiatry 58, 545-553
125. Gilad, G. M. and Gilad, V. H. (2007) Astroglia growth retardation and increased microglia proliferation by lithium and ornithine decarboxylase inhibitor in rat cerebellar cultures: Cytotoxicity by combined lithium and polyamine inhibition J. Neurosci. Res. 85, 594-601
126. Li, B., Gu, L., Zhang, H., Huang, J., Chen, Y., Hertz, L., and Peng, L. (2007) Up-regulation of cPLA(2) gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific Psychopharmacology (Berlin, Ger.) 194, 333-345
127. Su, H., Chu, T. H., and Wu, W. (2007) Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord Exp. Neurol. 206, 296-307
128. Beurel, E. and Jope, R. S. (2008) Differential regulation of STAT family members by glycogen synthase kinase-3 J. Biol. Chem. 283, 21934-21944
129. Rocha, E., Achaval, M., Santos, P., and Rodnight, R. (1998) Lithium treatment causes gliosis and modifies the morphology of hippocampal astrocytes in rats NeuroReport 9, 3971-3974
130. Yuskaitis, C. J., Beurel, E., and Jope, R. S. (2010) Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome Biochim. Biophys. Acta 1802, 1006-1012
131. Azim, K. and Butt, A. M. (2011) GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo Glia 59, 540-553
132. Yu, F., Wang, Z., Tanaka, M., Chiu, C. T., Leeds, P., Zhang, Y., and Chuang, D. M. (2012) Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury J. Neurosurg. 119, 766-773
133. Gao, M., Yan, X., and Weng, H. R. (2013) Inhibition of glycogen synthase kinase 3beta activity with lithium prevents and attenuates paclitaxel-induced neuropathic pain Neuroscience 254, 301-311
134. Davenport, C. M., Sevastou, I. G., Hooper, C., and Pocock, J. M. (2010) Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides J. Neurochem. 112, 552-563
135. Toledo, E. M. and Inestrosa, N. C. (2010) Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease Mol. Psychiatry 15, 272-285
136. Woodgett, J. R. (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A EMBO J. 9, 2431-2438
137. Grimes, C. A. and Jope, R. S. (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling Prog. Neurobiol. 65, 391-426
138. Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M. S., Jin, O., and Woodgett, J. R. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation Nature. 406, 86-90
139. Ghosh, S. and Hayden, M. S. (2008) New regulators of NF-kappaB in inflammation Nat. Rev. Immunol. 8, 837-848
140. Hofmann, C., Dunger, N., Schölmerich, J., Falk, W., and Obermeier, F. (2010) Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation Inflammatory Bowel Dis. 16, 1850-1858
141. Huang, W. C., Lin, Y. S., Wang, C. Y., Tsai, C. C., Tseng, H. C., Chen, C. L., Lu, P. J., Chen, P. S., Qian, L., Hong, J. S., and Lin, C. F. (2008) Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells Immunology. 128, e275-286
142. Schotte, P., Van Loo, G., Carpentier, I., Vandenabeele, P., and Beyaert, R. (2001) Lithium sensitizes tumor cells in an NF-kappa B-independent way to caspase activation and apoptosis induced by tumor necrosis factor (TNF). Evidence for a role of the TNF receptor-associated death domain protein J. Biol. Chem. 276, 25939-25945
143. Rao, R., Hao, C. M., and Breyer, M. D. (2004) Hypertonic stress activates glycogen synthase kinase 3beta-mediated apoptosis of renal medullary interstitial cells, suppressing an NFkappaB-driven cyclooxygenase-2-dependent survival pathway J. Biol. Chem. 279, 3949-3955